Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies
{{output}}
Efgartigimod is an established therapy for acetylcholine receptor antibody-positive generalized myasthenia gravis, yet real-world data on long-term overall responsiveness, response patterns, steroid-sparing effects, bridging therapy use, and predictors of bene... ...
